Edwards, T L
Groppe, M
MacLaren, R E
Article History
Received: 24 May 2014
Accepted: 2 November 2014
First Online: 16 January 2015
Competing interests
: REM is a Director of NightstarX Ltd (215 Euston Road, London, UK NW1 2BE), a choroideremia gene therapy company established and funded by the Wellcome Trust. The remaining authors declare no conflict of interest.